ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RVLP RVL Pharmaceuticals PLC

0.0282
0.00 (0.00%)
Pre Market
Last Updated: 10:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
RVL Pharmaceuticals PLC RVLP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.0282 10:00:00
Open Price Low Price High Price Close Price Previous Close
0.0282
more quote information »

Recent News

Date Time Source Heading
18/1/202408:05EDGAR2Form 8-K - Current report
21/12/202308:15EDGAR2Form 8-K - Current report
27/11/202322:50GLOBERVL Completes Financial Restructuring
17/11/202301:11EDGAR2Form DEF 14A - Other definitive proxy statements
02/11/202307:27EDGAR2Form SC 13D/A - General statement of acquisition of..
24/10/202307:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202304:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/10/202308:00EDGAR2Form 8-K - Current report
21/10/202306:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/10/202304:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202307:00EDGAR2Form 144 - Report of proposed sale of securities
14/10/202308:28EDGAR2Form SC 13D/A - General statement of acquisition of..
14/10/202307:15EDGAR2Form 8-K - Current report
12/10/202321:50GLOBERVL Pharmaceuticals plc Announces Prepackaged Reorganization..
30/9/202306:05EDGAR2Form 8-K - Current report
23/9/202306:05EDGAR2Form 8-K - Current report
06/9/202306:18EDGAR2Form DEF 14A - Other definitive proxy statements
06/9/202306:06EDGAR2Form 8-K - Current report
05/9/202321:45EDGAR2Form SC 13D - General statement of acquisition of beneficial..
01/9/202304:23EDGAR2Form D - Notice of Exempt Offering of Securities
26/8/202307:21EDGAR2Form PRE 14A - Other preliminary proxy statements
26/8/202306:17EDGAR2Form 8-K - Current report
24/8/202307:30EDGAR2Form S-3 - Registration statement under Securities Act of..
24/8/202306:05GLOBERVL Pharmaceuticals plc to Present at the H.C. Wainwright..
19/8/202306:06EDGAR2Form 8-K - Current report
18/8/202307:06EDGAR2Form SC 13D/A - General statement of acquisition of..
18/8/202307:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202306:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/8/202322:00GLOBERVL Pharmaceuticals plc Announces $5 Million Registered..
15/8/202307:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202323:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202321:51EDGAR2Form 8-K - Current report
14/8/202320:50GLOBERVL Pharmaceuticals plc Reports Second Quarter 2023..
03/8/202307:00EDGAR2Form 8-K - Current report
02/8/202322:30GLOBERVL Pharmaceuticals plc to Discuss Second Quarter 2023..
12/7/202311:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202311:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202320:50GLOBERVL Pharmaceuticals plc Provides Business Update

Your Recent History

Delayed Upgrade Clock